

Types of clinical evaluation routes


-
Scope: applicable to all medical devices. Equivalence with a device already on the market must be demonstrated in terms of technical, biological and clinical characteristics.
-
Technical: design, materials and manufacturing processes must be the same or similar.
-
Biological: biocompatibility, toxicity and degradation characteristics must be consistent.
-
Clinical: no significant differences in intended purpose, patient population, clinical performance, etc.

-
Scope: implantable or Class III devices that are modifications of a device already marketed by the same manufacturer, such as material upgrades or structural optimisation.
-
Demonstrating equivalence: equivalence with the original device must be shown in technical, biological and clinical characteristics.
-
Post-market clinical follow-up (PMCF): a PMCF plan must be drawn up to continuously monitor post-market data.

-
Scope: implantable or Class III devices.
-
Special requirement: when comparing with an equivalent device from another manufacturer, a contract must be in place to ensure access to the equivalent device’s technical documentation.

-
Scope: implantable or Class III devices certified under the MDD (Medical Devices Directive) or the AIMDD (Active Implantable Medical Devices Directive).
-
Clinical evidence requirement: PMCF data must be updated and integrated to demonstrate compliance with the MDR.

-
Scope: specific medical devices such as sutures, dental fillings, screws and bone plates.
-
Historical data requirement: a market safety record of at least 5–10 years must be provided, and clinical data on similar products may be cited. Where common specifications (CS) exist, compliance must be verified by testing.


-
Scope: low-risk devices such as laboratory equipment and non-invasive tools.
-
Special requirement: a thorough justification of why clinical data are not needed must be provided.
Steps for implementing an exemption from clinical investigation

-
Determine the route: identify the exemption route and the applicable Article.
-
Collect evidence: gather equivalence data, draw up the PMCF plan and other supporting evidence.
-
Prepare documentation: prepare the Clinical Evaluation Report (CER), risk management documentation and other necessary documents.
-
Notified body review: submit the documentation for review by the notified body (NB).
-
Post-market surveillance: implement the PMCF plan and update the CER regularly.
Key document checklist

-
Technical documentation (TCF): comprehensive information on the device’s technical aspects.
-
Clinical Evaluation Report (CER): the core document summarising the clinical evaluation process and results.
-
Post-market clinical follow-up plan (PMCF plan): the plan guiding post-market data monitoring.
-
Risk management documentation: records of the device’s risk management process.


More articles:
The Free Sale Certificate (FSC): A “Passport” for Global Medical Device Trade
A Special Route for E-Cigarettes to Enter the EU Outside the TPD


